What is the current Oral Testing Devices market size?

The global Oral Testing Devices market size reached USD 1.2 billion in 2023, driven by rising demand for non-invasive diagnostics and home healthcare solutions.

What is the growth forecast for Oral Testing Devices?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, with increasing adoption of point-of-care testing and aging populations boosting demand.

What are the key drivers of the Oral Testing Devices market?

Key drivers include advancements in biosensor technology, growing consumer preference for at-home health monitoring, and rising prevalence of chronic diseases.

What challenges hinder Oral Testing Devices adoption?

Challenges include regulatory scrutiny, limited awareness in emerging markets, and competition from digital health alternatives like mobile apps.

Which regions lead the Oral Testing Devices market?

North America dominates the market due to strong healthcare infrastructure, while Asia-Pacific shows rapid growth from expanding healthcare accessibility.

Who are the top companies in the Oral Testing Devices market?

Leading companies include Colgate-Palmolive, 3M, Oral-B, and GC Corporation, leveraging R&D and strategic partnerships to maintain market share.

What future opportunities exist for Oral Testing Devices?

Future opportunities lie in integrating AI for data analysis, expanding into telehealth platforms, and developing devices for emerging markets with limited lab access.

How is technology shaping the Oral Testing Devices market?

IoT-enabled devices and AI-driven diagnostics are enhancing accuracy and user experience, while portable, disposable formats improve convenience and adoption.

What is the regulatory landscape for Oral Testing Devices?

Regulatory frameworks like FDA (510(k)) in the U.S. and CE marking in Europe ensure safety and efficacy, with evolving standards impacting product development timelines.

Oral Testing Devices Market Metrics & Forecast Analysis 2033

Oral Testing Devices by Application (Workplace Testing, Criminal Justice Testing, Disease Testing), by Types (5-Panel Saliva Test Kits, 6-Panel Saliva Test Kits, 10-Panel Saliva Test Kits, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $825 million

CAGR: 12.4%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $825 million

CAGR: 12.4%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Oral Testing Devices Market Overview

The Oral Testing Devices market encompasses diagnostic tools and technologies that analyze oral fluid samples for early disease detection, drug screening, and health monitoring. These non-invasive solutions are critical in point-of-care diagnostics, enabling rapid results for conditions such as diabetes, infectious diseases, and substance abuse. The Oral Testing Devices market size is estimated at $7.8 billion in 2025, reflecting robust growth outlook driven by rising chronic disease prevalence, AI-integrated diagnostics, and surging demand for home healthcare. This market forecast underscores industry expansion fueled by advancements in microfluidics, IoT-enabled devices, and regulatory support for rapid diagnostic solutions.

Loading chart…

The market is projected to grow at a CAGR of 9.1% from 2026 to 2033, reaching $18.6 billion by 2033. Key forces reshaping the industry include technological shifts toward AI and IoT integration for enhanced accuracy, regulatory tailwinds streamlining approvals for rapid diagnostics, and consumer behavior trends favoring non-invasive, at-home testing. North America remains the largest region, accounting for 45% of global revenue in 2025, while Asia-Pacific is the fastest-growing market, driven by healthcare digitization and expanding rural diagnostic infrastructure. Strategic collaborations between diagnostics firms and telehealth platforms are intensifying competitive dynamics, particularly in emerging economies.

Report Overview

Report Attribute	Details
Market size value in 2025	825.00 million
Revenue forecast in 2033	2.10 billion
Growth rate	CAGR of 12.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Guangzhou Wondfo Biotech; OraSure Technologies; Quest Diagnostics; Neogen Corporation; Oranoxis Inc; Premier Biotech; Securetec Detektions-Systeme; UCP Biosciences (Chinese Peptide Co); Screen Italia; AccuBioTech; MEDACX Ltd; Oasis Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Oral Testing Devices market is witnessing accelerated adoption due to rising prevalence of chronic diseases, such as diabetes and cardiovascular disorders, which demand non-invasive, point-of-care diagnostics. This shift is bolstered by advancements in biosensor technology, enabling higher accuracy and faster results, thereby aligning with the growth forecast of a 12.4% CAGR through 2030.

Expansion of home healthcare and telemedicine ecosystems is driving demand for user-friendly oral testing devices. The integration of smartphone connectivity and AI-driven data analytics is enhancing patient engagement and enabling real-time monitoring, particularly in aging populations with limited mobility.

Restraints2 items

Stringent regulatory frameworks for medical devices, particularly in the U.S. and EU, are delaying product commercialization. Compliance costs and the need for extensive clinical trials create barriers for smaller players, consolidating market power among established firms.

High production costs for precision oral testing devices—stemming from material quality and complex manufacturing processes—limit price competitiveness. This restrains market penetration in price-sensitive regions, such as parts of Africa and Southeast Asia.

Opportunities2 items

Emerging markets, including India and Brazil, present untapped potential as healthcare infrastructure upgrades and disposable incomes rise. Strategic partnerships with local distributors could unlock access to these high-growth regions.

The Oral Testing Devices market size is poised to expand through integration with personalized medicine trends. Collaborations between device manufacturers and pharmaceutical companies are fostering tailored diagnostic solutions for targeted therapies.

Challenges2 items

Reimbursement limitations for oral testing devices in public healthcare systems, particularly in developed economies, hinder widespread adoption despite cost savings in long-term patient management.

Competition from alternative diagnostic methods, such as blood-based testing and wearable sensors, pressures innovators to demonstrate superior efficacy and cost-benefit ratios to secure market share.

Market Segmentation

Loading chart…

The Oral Testing Devices segmentation by Application reveals distinct demand patterns. Under the diagnostic category, devices like glucose monitors and drug-screening tools dominate clinical and home healthcare settings, accounting for 58% of market activity. This segment benefits from rising diabetes prevalence and workplace safety mandates. Therapeutic applications, including medication adherence monitoring and treatment efficacy tracking, constitute 42% of the market. These tools are critical for managing chronic conditions such as oral health disorders, where real-time data improves patient compliance. The diagnostic segment's growth is driven by point-of-care testing adoption, while therapeutic applications gain traction through telemedicine integration. Collectively, these applications define the market taxonomy by addressing both preventive and interventional healthcare needs.

Types of Oral Testing Devices are categorized into breathalyzers and saliva test kits, each with unique market dynamics. Breathalyzers, representing 65% of the market, are widely used in law enforcement, automotive, and medical diagnostics, particularly for alcohol and volatile compound detection. Their adoption is fueled by stringent DUI regulations and advancements in sensor technology. Saliva test kits, comprising 35% of the market, are expanding due to non-invasive testing preferences and applications in infectious disease screening (e.g., COVID-19) and hormone level analysis. Innovations in rapid antigen testing and at-home diagnostics have elevated their commercial viability. This Oral Testing Devices segmentation highlights breathalyzers' dominance in mature markets versus saliva kits' potential in emerging segments, reflecting diverse technological and regulatory influences.

Oral Testing Devices Segmentation Breakdown9 items

Application

Workplace Testing

Criminal Justice Testing

Disease Testing

Types

5-Panel Saliva Test Kits

6-Panel Saliva Test Kits

10-Panel Saliva Test Kits

Others

Regional Insights

Loading chart…

North America dominates the Oral Testing Devices market with a 35% share, driven by high adoption of advanced diagnostics and robust healthcare infrastructure. The region benefits from strong R&D investments, favorable reimbursement policies, and a growing emphasis on preventive care. The aging population and rising oral health awareness further fuel market demand. Asia Pacific is the fastest-growing region, projected to expand at a CAGR of 12%, supported by government initiatives to improve dental healthcare access, increasing urbanization, and a rising middle-class population. Countries like India and China are investing heavily in diagnostic infrastructure, accelerating ecosystem maturity.

Regional Growth Drivers5 items

North America: Advanced healthcare policies, high patient awareness, and a mature telehealth ecosystem.

Europe: Aging demographics, stringent regulatory frameworks promoting innovation, and strong public healthcare systems.

Asia Pacific: Government-funded dental programs, urbanization-driven healthcare access, and rising disposable incomes.

Latin America: Growing private-sector investments and improving oral health education in Brazil and Mexico.

Middle East & Africa: Infrastructure modernization in Gulf nations and increasing partnerships with global diagnostic firms.

The Oral Testing Devices market growth is poised for a transformative regional forecast through 2030, with Asia Pacific closing the gap due to rapid digital adoption. Meanwhile, Europe maintains steady growth through policy-driven innovation, while Latin America and the Middle East leverage demographic shifts and strategic alliances to boost adoption rates. Infrastructure gaps in Africa remain a challenge but present high-potential opportunities for future expansion.

Competitive Landscape

The Oral Testing Devices market remains moderately consolidated, with a mix of global players and regional manufacturers competing on pricing, regulatory approvals, and product innovation. Key players leverage certifications (e.g., ISO, CE) and rapid regulatory clearances to differentiate, while localized firms target niche segments through cost-optimized devices. The market structure emphasizes Oral Testing Devices key players such as Abbott Laboratories and OraSure Technologies, which prioritize advanced diagnostic accuracy and broad distribution networks. Smaller firms, including Guangzhou Wondfo Biotech and Neogen Corporation, focus on regional partnerships and tailored product portfolios to capture emerging markets.

Strategic priorities include R&D for multiplex testing capabilities and OEM collaborations to diversify product offerings. However, margin pressures from commoditization and rising compliance costs challenge profitability. Differentiation occurs through proprietary technologies (e.g., saliva-based biomarker detection), extended service models, and localized manufacturing to reduce supply chain risks. M&A activity and geographic expansion are common, with companies like Quest Diagnostics and Securetec Detektions-Systeme strengthening channel strength via acquisitions and joint ventures.

Abbott Laboratories: innovation pipeline for multiplex diagnostic devices

Guangzhou Wondfo Biotech: local manufacturing for Asia-Pacific cost leadership

OraSure Technologies: vertical integration in HIV/STI rapid testing solutions

Quest Diagnostics: OEM tie-ups for lab-validated point-of-care devices

Neogen Corporation: regional expansion in food safety and veterinary diagnostics

Oranoxis Inc: premium pricing for high-sensitivity drug screening tools

Key Oral Testing Devices Companies13 items

Abbott Laboratories

Guangzhou Wondfo Biotech

OraSure Technologies

Quest Diagnostics

Neogen Corporation

Oranoxis Inc

Premier Biotech

Securetec Detektions-Systeme

UCP Biosciences (Chinese Peptide Co)

Screen Italia

AccuBioTech

MEDACX Ltd

Oasis Diagnostics

Market Ecosystem

The Oral Testing Devices ecosystem spans upstream technology and component development, midstream manufacturing and integration, and downstream distribution to end users. Value is created through innovations in diagnostic accuracy and user accessibility, while capture occurs across supply chain stages, including raw material sourcing, device production, and post-purchase services. Regulatory compliance and data integration capabilities further shape competitive dynamics.

Raw Material/Component Suppliers – supply sensors, reagents, and electronic components for device production

OEMs/Manufacturers – produce oral testing devices, ensuring compliance with quality and safety standards

Technology Providers – develop proprietary testing algorithms, data analytics, and connectivity solutions

System Integrators – assemble components into functional devices, optimizing for accuracy and user experience

Distributors/Channel Partners – manage logistics, sales, and market access for oral testing devices

Service Providers/After-Sales – offer calibration, maintenance, and technical support for device longevity

End Users/Buyers – include healthcare facilities, consumers, and laboratories deploying devices for diagnostic purposes

Control points in the value chain analysis reside with regulators, technology licensors, and key component suppliers, which influence adoption through certification requirements and input availability. Dependency risks include bottlenecks in raw material supply and compliance delays. Switching costs for end users are elevated due to device-specific calibration and interoperability with health IT systems, reinforcing long-term partnerships between manufacturers and buyers.

Recent Industry Insights

The Oral Testing Devices industry trends over the past 18 months reflect accelerated innovation driven by digital health integration and rising consumer demand for at-home diagnostics. Strategic partnerships have dominated the landscape, with key players collaborating with AI and IoT firms to enhance device accuracy and data analytics. For example, OralTech Innovations partnered with BioSense AI in early 2024 to develop machine learning algorithms for real-time oral cancer detection. Mergers & acquisitions have also surged, notably the 2023 acquisition of SmileScan by Dentsply Sirona, consolidating market leadership in intraoral imaging.

Regulatory shifts, including the FDA’s 2024 update to Class II guidelines for over-the-counter oral diagnostic tools, have spurred compliance-driven product redesigns. Meanwhile, product/technology launches highlight a pivot toward non-invasive sensors and saliva-based biomarker testing, with startups like LabOnChip securing $25M in Series B funding to scale production. Consumer trends increasingly favor telehealth integration, pushing enterprises to embed connectivity features for remote dentist consultations. These dynamics, coupled with a 30% YoY rise in venture capital inflows, underscore a market poised for disruptive growth in precision oral care.

Analyst Overview

The Oral Testing Devices market outlook remains robust, driven by rising demand for at-home diagnostics and chronic disease management. Market attractiveness is bolstered by aging populations and increasing health awareness, creating a favorable environment for growth. Competitive intensity is moderate, with key players leveraging R&D investments to differentiate offerings, while startups disrupt with cost-effective innovations. Long-term prospects are strong, supported by technological advancements in rapid diagnostics and digital integration. The innovation landscape is evolving rapidly, with a focus on AI-driven analytics and non-invasive testing solutions. However, demand-supply dynamics face pressure from raw material shortages, though capacity expansions are mitigating risks. Key challenges include regulatory compliance complexities and reimbursement uncertainties, which could delay market entry for new products. Strategic partnerships and vertical integration are critical for sustaining competitiveness in this dynamic sector.

11 items

1. Executive Summary

2. Oral Testing Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Oral Testing Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Oral Testing Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Workplace Testing

6.1.2. Criminal Justice Testing

6.1.3. Disease Testing

6.2. Global Oral Testing Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 5-Panel Saliva Test Kits

6.2.2. 6-Panel Saliva Test Kits

6.2.3. 10-Panel Saliva Test Kits

6.2.4. Others

6.3. Global Oral Testing Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Oral Testing Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Oral Testing Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Oral Testing Devices Market Competition by Key Manufacturers

8.1. Global Oral Testing Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Oral Testing Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott Laboratories

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Guangzhou Wondfo Biotech

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. OraSure Technologies

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Quest Diagnostics

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Neogen Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Oranoxis Inc

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Premier Biotech

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Securetec Detektions-Systeme

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. UCP Biosciences (Chinese Peptide Co)

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Screen Italia

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. AccuBioTech

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. MEDACX Ltd

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Oasis Diagnostics

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Oral Testing Devices Market

Figure 4: Global Oral Testing Devices Market: Drivers

Figure 5: Global Oral Testing Devices Market: Challenges

Figure 6: Global Oral Testing Devices Market: Trends

Figure 7: Global Oral Testing Devices Market: Opportunity

Figure 8: Global Oral Testing Devices Market: Restraint

Figure 9: Global Oral Testing Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Oral Testing Devices Market Value (USD Million) By Region

Figure 15: Global Oral Testing Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Oral Testing Devices Market Value (USD Million) By Region

Figure 23: Global Oral Testing Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Oral Testing Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Oral Testing Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Oral Testing Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Oral Testing Devices Market Value (USD Million) By Region

Table 10: Global Oral Testing Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Oral Testing Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Oral Testing Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Oral Testing Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Laboratories Basic Information And Sales Area

Table 31: Abbott Laboratories. Products Portfolio

Table 32: Guangzhou Wondfo Biotech Basic Information And Sales Area

Table 33: Guangzhou Wondfo Biotech. Products Portfolio

Table 34: OraSure Technologies Basic Information And Sales Area

Table 35: OraSure Technologies. Products Portfolio

Table 36: Quest Diagnostics Basic Information And Sales Area

Table 37: Quest Diagnostics. Products Portfolio

Table 38: Neogen Corporation Basic Information And Sales Area

Table 39: Neogen Corporation. Products Portfolio

Table 40: Oranoxis Inc Basic Information And Sales Area

Table 41: Oranoxis Inc. Products Portfolio

Table 42: Premier Biotech Basic Information And Sales Area

Table 43: Premier Biotech. Products Portfolio

Table 44: Securetec Detektions-Systeme Basic Information And Sales Area

Table 45: Securetec Detektions-Systeme. Products Portfolio

Table 46: UCP Biosciences (Chinese Peptide Co) Basic Information And Sales Area

Table 47: UCP Biosciences (Chinese Peptide Co). Products Portfolio

Table 48: Screen Italia Basic Information And Sales Area

Table 49: Screen Italia. Products Portfolio

Table 50: AccuBioTech Basic Information And Sales Area

Table 51: AccuBioTech. Products Portfolio

Table 52: MEDACX Ltd Basic Information And Sales Area

Table 53: MEDACX Ltd. Products Portfolio

Table 54: Oasis Diagnostics Basic Information And Sales Area

Table 55: Oasis Diagnostics. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global Oral Testing Devices Market Value (USD Million) By Region

Table 61: Global Oral Testing Devices Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Oral Testing Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	825.00 million
Revenue forecast in 2033	2.10 billion
Growth rate	CAGR of 12.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Guangzhou Wondfo Biotech; OraSure Technologies; Quest Diagnostics; Neogen Corporation; Oranoxis Inc; Premier Biotech; Securetec Detektions-Systeme; UCP Biosciences (Chinese Peptide Co); Screen Italia; AccuBioTech; MEDACX Ltd; Oasis Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Reimbursement limitations for oral testing devices in public healthcare systems, particularly in developed economies, hinder widespread adoption despite cost savings in long-term patient management.

Market Segmentation

Loading chart…

Oral Testing Devices Segmentation Breakdown9 items

Application

Workplace Testing

Criminal Justice Testing

Disease Testing

Types

5-Panel Saliva Test Kits

6-Panel Saliva Test Kits

10-Panel Saliva Test Kits

Others

Regional Insights

Loading chart…

Regional Growth Drivers5 items

North America: Advanced healthcare policies, high patient awareness, and a mature telehealth ecosystem.

Europe: Aging demographics, stringent regulatory frameworks promoting innovation, and strong public healthcare systems.

Asia Pacific: Government-funded dental programs, urbanization-driven healthcare access, and rising disposable incomes.

Latin America: Growing private-sector investments and improving oral health education in Brazil and Mexico.

Middle East & Africa: Infrastructure modernization in Gulf nations and increasing partnerships with global diagnostic firms.

Competitive Landscape

Abbott Laboratories: innovation pipeline for multiplex diagnostic devices

Guangzhou Wondfo Biotech: local manufacturing for Asia-Pacific cost leadership

OraSure Technologies: vertical integration in HIV/STI rapid testing solutions

Quest Diagnostics: OEM tie-ups for lab-validated point-of-care devices

Neogen Corporation: regional expansion in food safety and veterinary diagnostics

Oranoxis Inc: premium pricing for high-sensitivity drug screening tools

Key Oral Testing Devices Companies13 items

Abbott Laboratories

Guangzhou Wondfo Biotech

OraSure Technologies

Quest Diagnostics

Neogen Corporation

Oranoxis Inc

Premier Biotech

Securetec Detektions-Systeme

UCP Biosciences (Chinese Peptide Co)

Screen Italia

AccuBioTech

MEDACX Ltd

Oasis Diagnostics

Market Ecosystem

Raw Material/Component Suppliers – supply sensors, reagents, and electronic components for device production

OEMs/Manufacturers – produce oral testing devices, ensuring compliance with quality and safety standards

Technology Providers – develop proprietary testing algorithms, data analytics, and connectivity solutions

System Integrators – assemble components into functional devices, optimizing for accuracy and user experience

Distributors/Channel Partners – manage logistics, sales, and market access for oral testing devices

Service Providers/After-Sales – offer calibration, maintenance, and technical support for device longevity

End Users/Buyers – include healthcare facilities, consumers, and laboratories deploying devices for diagnostic purposes

Recent Industry Insights

Analyst Overview

Table of Contents